Table 1

Baseline characteristics of the GAIT and PROCARDIS study cohorts

CharacteristicGAIT study (n = 399)PROCARDIS study (n = 1238)
Median age, y (range) 37.7 (1-87) 62 (57-66) 
Women, no. (%) 217 (54.4) 236 (18.7) 
Current smoker, no. (%) 151 (37.8) 708 (56.0) 
Lipid-lowering treatment, no. (%) 28 (7.0) 910 (71.9) 
Antihypertensive treatment, no. (%) 30 (7.5) 1010 (79.8) 
Mean body mass index, kg/m2 (SD) 24.8 (4.9) 28.1 (4.12) 
Mean HDL cholesterol (SD) 1.42 (0.37) 1.14 (0.29) 
Mean LDL cholesterol (SD) 3.27 (1.0) 2.82 (0.81) 
Mean triglycerides (SD) 1.12 (0.88) 1.87 (1.14) 
Median fibrinogen, g/L (interquartile range) 3.2 (1.6-5.8) 3.7 (3.3-4.3) 
Median homocysteine, total, mg/L (interquartile range) 7.74 (2.7-23.8) 12.2 (9.9-14.9) 
Median estimated glomerular filtration rate, mL/min/kg2 (interquartile range) NA 74.8 (62-89) 
CharacteristicGAIT study (n = 399)PROCARDIS study (n = 1238)
Median age, y (range) 37.7 (1-87) 62 (57-66) 
Women, no. (%) 217 (54.4) 236 (18.7) 
Current smoker, no. (%) 151 (37.8) 708 (56.0) 
Lipid-lowering treatment, no. (%) 28 (7.0) 910 (71.9) 
Antihypertensive treatment, no. (%) 30 (7.5) 1010 (79.8) 
Mean body mass index, kg/m2 (SD) 24.8 (4.9) 28.1 (4.12) 
Mean HDL cholesterol (SD) 1.42 (0.37) 1.14 (0.29) 
Mean LDL cholesterol (SD) 3.27 (1.0) 2.82 (0.81) 
Mean triglycerides (SD) 1.12 (0.88) 1.87 (1.14) 
Median fibrinogen, g/L (interquartile range) 3.2 (1.6-5.8) 3.7 (3.3-4.3) 
Median homocysteine, total, mg/L (interquartile range) 7.74 (2.7-23.8) 12.2 (9.9-14.9) 
Median estimated glomerular filtration rate, mL/min/kg2 (interquartile range) NA 74.8 (62-89) 

The GAIT study19  was performed to investigate genetic susceptibility to idiopathic thrombophilia and the PROCARDIS study20,21  was performed to identify susceptibility genes for premature MI.

HDL indicates high-density lipoprotein; LDL, low-density lipoprotein; and NA, not available.

Close Modal

or Create an Account

Close Modal
Close Modal